Alligator Bioscience To Address Immunogenicity With Epibase(R)
Published: Oct 10, 2006
Lund, Sweden and Ghent, Belgium - October 09, 2006 - Alligator Bioscience AB and AlgoNomics NV today announced that they have entered into a collaboration. AlgoNomics will employ its Epibase® platform to complement Alligator Bioscience in the optimization of therapeutic proteins both in their internal projects and in collaborative projects with customers. The collaboration allows Alligator to maximally reduce immunogenicity upon optimization of protein therapeutics with their proprietary ssDNA recombination technology FIND®.